Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)
1
Centre for Radiation and Environmental Science, FOCAS Research Institute, Technological University Dublin, D02 HW71 Dublin, Ireland
2
School of Physics & Clinical & Optometric Sciences, Technological University Dublin, Grangegorman, D07 XT95 Dublin, Ireland
3
Scottish HPV Reference Laboratory, Department of Laboratory Medicine, NHS Lothian, 51 Little France Crescent, Edinburgh EH16 5SA, UK
4
HPV Research Group, Centre for Reproductive Health, Queens Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK
5
Discipline of Histopathology, University of Dublin Trinity College, D08 NHY1 Dublin, Ireland
6
CERVIVA Molecular Pathology Research Laboratory, The Coombe Women and Infants University Hospital, D08 XW7X Dublin, Ireland
7
The Trinity St. James’s Cancer Institute, D08 NHY1 Dublin, Ireland
8
Department of Obstetrics and Gynaecology, The Coombe Women and Infants University Hospital, D08 XW7X Dublin, Ireland
*
Author to whom correspondence should be addressed.
Academic Editor: Ruud L. M. Bekkers
Cancers 2022, 14(7), 1836; https://doi.org/10.3390/cancers14071836
Received: 12 March 2022
/
Accepted: 1 April 2022
/
Published: 6 April 2022
(This article belongs to the Special Issue Biophotonics and Imaging for Cancer Screening, Diagnosis and Treatment Monitoring)
Simple Summary
There is an unmet clinical need for new methods to aid clinicians in the early detection of cervical cancer and precancer. Spectroscopic methods such as Raman spectroscopy can provide a rapid, label-free and nondestructive measurement of the biochemical fingerprint of cells, tissues and biofluids. This study aims to demonstrate the clinical utility of Raman spectroscopy for the identification of cervical precancer. Raman spectra were recorded from cervical smear samples (n = 662) and a classifier was developed based on histology. A classification accuracy of 91.3% was achieved in an independent blinded test set (n = 69), demonstrating the potential clinical utility of Raman spectroscopy.
The mortality associated with cervical cancer can be reduced if detected at the precancer stage, but current methods are limited in terms of subjectivity, cost and time. Optical spectroscopic methods such as Raman spectroscopy can provide a rapid, label-free and nondestructive measurement of the biochemical fingerprint of a cell, tissue or biofluid. Previous studies have shown the potential of Raman spectroscopy for cervical cancer diagnosis, but most were pilot studies with small sample sizes. The aim of this study is to show the clinical utility of Raman spectroscopy for identifying cervical precancer in a large sample set with validation in an independent test set. Liquid-based cervical cytology samples (n = 662) (326 negative, 200 cervical intraepithelial neoplasia (CIN)1 and 136 CIN2+) were obtained as a training set. Raman spectra were recorded from single-cell nuclei and subjected to a partial least squares discriminant analysis (PLSDA). In addition, the PLSDA classification model was validated using a blinded independent test set (n = 69). A classification accuracy of 91.3% was achieved with only six of the blinded samples misclassified. This study showed the potential clinical utility of Raman spectroscopy with a good classification of negative, CIN1 and CIN2+ achieved in an independent test set.
View Full-Text
Keywords:
Raman spectroscopy; cytology; ThinPrep; exfoliated cells; cervical precancer; cervical intraepithelial neoplasia (CIN); HPV
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Supplementary File 1:
ZIP-Document (ZIP, 31 KiB)
MDPI and ACS Style
Traynor, D.; Duraipandian, S.; Bhatia, R.; Cuschieri, K.; Tewari, P.; Kearney, P.; D’Arcy, T.; O’Leary, J.J.; Martin, C.M.; Lyng, F.M. Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN). Cancers 2022, 14, 1836. https://doi.org/10.3390/cancers14071836
AMA Style
Traynor D, Duraipandian S, Bhatia R, Cuschieri K, Tewari P, Kearney P, D’Arcy T, O’Leary JJ, Martin CM, Lyng FM. Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN). Cancers. 2022; 14(7):1836. https://doi.org/10.3390/cancers14071836
Chicago/Turabian StyleTraynor, Damien, Shiyamala Duraipandian, Ramya Bhatia, Kate Cuschieri, Prerna Tewari, Padraig Kearney, Tom D’Arcy, John J. O’Leary, Cara M. Martin, and Fiona M. Lyng. 2022. "Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)" Cancers 14, no. 7: 1836. https://doi.org/10.3390/cancers14071836
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
